Correction
A set of NF-kappaB-regulated microRNAs induces acquired TRAIL resistance in Lung cancer
Paper Information
Record ID:
8816
Author(s):
Journal:
Publication Date:
June 15, 2015
Retraction Date:
March 13, 2017
(8.7 years years ago)
Subjects:
Specific Fields:
Biology - Cancer Biology - Cellular Genetics Medicine - Oncology Medicine - Pulmonology
Biology - Cancer Biology - Cellular Genetics Medicine - Oncology Medicine - Pulmonology
Institutions:
- Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, OH 43210
- Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030
- Department of Experimental Oncology and Molecular Medicine, Start Up Unit, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale per lo Studio e la Cura dei Tumori, 20133 Milan, Italy
- Department of Morphology and Embryology, Human Anatomy Section, University of Ferrara, 44100 Ferrara, Italy
- Department of Molecular Biosciences, University of Texas at Austin, Austin, TX 78712
- Department of Life Systems, Sookmyung Women’s University, Seoul 140-742, Republic of Korea
- Transcriptional Networks in Lung Cancer Group, Cancer Research United Kingdom Manchester Institute, University of Manchester, Manchester M20 4BX, United Kingdom
Countries:
Article Type:
Publisher:
National Academy of Sciences (NAS)
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Correction Details
Retraction Reasons:
Nature of Retraction:
Correction
Retraction Notice:
10.1073/pnas.1701795114Additional Notes:
see also: https://www.nytimes.com/2017/03/08/science/cancer-carlo-croce.html?hp&action=click&pgtype=Homepage&clickSource=image&module=photo-spot-region®ion=top-news&WT.nav=top-news&_r=2
Citations (71)
71
Total Citations54
Post-Retraction(76.1%)
16
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
13
Within 1 year
31
After 2+ years
2936
Days since retraction (latest)
Paper citing miR-221&222 Regulate TRAIL Resistance and Enhance ...
Unknown Authors
Unknown Journal
Published: Unknown
MicroRNA-99 family in cancer: molecular mechanisms for clinical applications
Yueyuan Wang, Dan Huang, Mingxi Li et al. (4 authors)
PeerJ
Open Access
Published: Mar 2025
2 citations
2 citations
2936 days after retraction
A seven-LncRNA signature for prognosis prediction of patients with lung squamous cell carcinoma through tumor immune escape
Qiangqiang Ge, Lin Zhong, Xuequan Wang et al. (5 authors)
Frontiers in Oncology
Open Access
Published: Mar 2025
2933 days after retraction
Extracellular vesicle‐encapsulated <scp>miR</scp>‐30c‐5p reduces aging‐related liver fibrosis
Alice Cristina Rodrigues, Yujing J. Heng, Frank J. Slack
Aging Cell
Open Access
Published: Sep 2024
2 citations
2 citations
2741 days after retraction
<i>MiR-29</i> and <i>MiR-140</i> regulate TRAIL-induced drug tolerance in lung cancer
Suyeon Kim, Ki Wook Lee, Yongjin Yoo et al. (20 authors)
Animal Cells and Systems
Open Access
Published: Apr 2024
2605 days after retraction
E-cadherin re-expression: Its potential in combating TRAIL resistance and reversing epithelial-to-mesenchymal transition
Ser Hui San, Siew Ching Ngai
Gene
Open Access
Published: Feb 2024
8 citations
8 citations
2532 days after retraction
A seven-Lnc RNA signature for prognosis prediction of patients with lung squamous cell carcinoma through tumor immune escape
Lin Zhong, Yan Hu
Research Square (Research Square)
Open Access
Published: May 2023
2248 days after retraction
Pre-Protection and Mechanism of Crude Extracts from Dioscorea alata L. on H2O2-Induced IPEC-J2 Cells Oxidative Damage
Yanhong Yun, Huiyu Shi, Yanyu Wang et al. (8 authors)
Animals
Open Access
Published: Apr 2023
2 citations
2 citations
2228 days after retraction
Apoptosis evasion via long non-coding RNAs in colorectal cancer
Muhammad Irfan, Zeeshan Javed, Khushbukhat Khan et al. (8 authors)
Cancer Cell International
Open Access
Published: Sep 2022
30 citations
30 citations
2005 days after retraction
Tumor-Targeted miRNA Nanomedicine for Overcoming Challenges in Immunity and Therapeutic Resistance
Neha N. Parayath, Srujan Gandham, Mansoor M. Amiji
Nanomedicine
Open Access
Published: Aug 2022
13 citations
13 citations
1967 days after retraction
EV-Mediated Chemoresistance in the Tumor Microenvironment: Is NF-κB a Player?
Mauro Di Vito Nolfi, Davide Vecchiotti, Irene Flati et al. (8 authors)
Frontiers in Oncology
Open Access
Published: Jun 2022
4 citations
4 citations
1927 days after retraction
The lncRNA CASC2 Modulates Hepatocellular Carcinoma Cell Sensitivity and Resistance to TRAIL Through Apoptotic and Non-Apoptotic Signaling
Jichun Sun, Hongbo Xu, Lei Zhao et al. (9 authors)
Frontiers in Oncology
Open Access
Published: Jan 2022
5 citations
5 citations
1779 days after retraction
Role of TRAIL-mediated signaling as Jekyll and Hyde in metastasis
Ammad Ahmad Farooqı, Iqra Mobeen, Rükset Attar et al. (4 authors)
Elsevier eBooks
Published: Jan 2022
1755 days after retraction
MicroRNAs in Cancer
Hamed Mirzaei, Neda Rahimian, Hamid Reza Mirzaei et al. (5 authors)
Synthesis lectures on biomedical engineering
Published: Jan 2022
7 citations
7 citations
1755 days after retraction
Flower‐Like Nanozymes with Large Accessibility of Single Atom Catalysis Sites for ROS Generation Boosted Tumor Therapy
Yuxin Xing, Lu Wang, Liucan Wang et al. (10 authors)
Advanced Functional Materials
Published: Dec 2021
61 citations
61 citations
1754 days after retraction
Kaempferol sensitizes tumor necrosis factor-related apoptosis-inducing ligand-resistance chronic myelogenous leukemia cells to apoptosis
Raedeh Saraei, Heshu Sulaiman Rahman, Masoud Soleimani et al. (7 authors)
Molecular Biology Reports
Published: Nov 2021
9 citations
9 citations
1717 days after retraction
RETRACTED: Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges
Ehsan Razeghian, Wanich Suksatan, Heshu Sulaiman Rahman et al. (9 authors)
Frontiers in Immunology
Open Access
Published: Aug 2021
41 citations
41 citations
1621 days after retraction
Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy
Jolanta Kryczka, Jakub Kryczka, Karolina H. Czarnecka et al. (4 authors)
International Journal of Molecular Sciences
Open Access
Published: Aug 2021
118 citations
118 citations
1619 days after retraction
Paper citing A set of NF-kappaB-regulated microRNAs induces acq...
Unknown Authors
Unknown Journal
Published: May 2021
1513 days after retraction
miR-21: A Key Small Molecule with Great Effects in Combination Cancer Therapy
Nahid Arghiani, Maryam Moghaddam Matin
Nucleic Acid Therapeutics
Published: Apr 2021
37 citations
37 citations
1502 days after retraction
MicroRNAs: Emerging oncogenic and tumor-suppressive regulators, biomarkers and therapeutic targets in lung cancer
Shengjie Tang, Shuangjiang Li, Tao Liu et al. (8 authors)
Cancer Letters
Published: Jan 2021
46 citations
46 citations
1403 days after retraction
TRAIL receptor-induced features of epithelial-to-mesenchymal transition increase tumour phenotypic heterogeneity: potential cell survival mechanisms
Ludovic Peyre, Mickaël Meyer, Paul Hofman et al. (4 authors)
British Journal of Cancer
Open Access
Published: Dec 2020
24 citations
24 citations
1359 days after retraction
MicroRNA‐99 family in cancer and immunity
Joseph Eniafe, Shuai Jiang
Wiley Interdisciplinary Reviews - RNA
Published: Nov 2020
39 citations
39 citations
1351 days after retraction
The multifaceted role of TRAIL signaling in cancer and immunity
Ludmila Cardoso Alves, Nadia Corazza, Olivier Micheau et al. (4 authors)
FEBS Journal
Open Access
Published: Nov 2020
95 citations
95 citations
1348 days after retraction
PD-L1 Under Regulation of miR-429 Influences the Sensitivity of Gastric Cancer Cells to TRAIL by Binding of EGFR
Jinqi Lv, Tianshu Guo, Xiujuan Qu et al. (11 authors)
Frontiers in Oncology
Open Access
Published: Jul 2020
19 citations
19 citations
1227 days after retraction
PD173074 blocks G1/S transition via CUL3-mediated ubiquitin protease in HepG2 and Hep3B cells
Chuchu Qiao, Hongyan Qian, Jue Wang et al. (8 authors)
PLoS ONE
Open Access
Published: Jun 2020
1 citation
1 citation
1193 days after retraction
Crosstalk of MicroRNAs and Oxidative Stress in the Pathogenesis of Cancer
Can Lu, Danting Zhou, Qiang Wang et al. (7 authors)
Oxidative Medicine and Cellular Longevity
Open Access
Published: Apr 2020
60 citations
60 citations
1142 days after retraction
MicroRNAs as Emerging Regulators of Signaling in the Tumor Microenvironment
Shahzad N. Syed, Bernhard Brüne
Cancers
Open Access
Published: Apr 2020
27 citations
27 citations
1122 days after retraction
SANTAMARINE: Mechanistic studies on multiple diseases
Sajid Jalal, Bashir Ahmad, Ting Zhang et al. (5 authors)
Chemical Biology & Drug Design
Published: Feb 2020
22 citations
22 citations
1059 days after retraction
MicroRNA-18a promotes cancer progression through SMG1 suppression and mTOR pathway activation in nasopharyngeal carcinoma
Shi-Juan Mai, Ruo-Wen Xiao, Lu Shi et al. (13 authors)
Cell Death and Disease
Open Access
Published: Oct 2019
44 citations
44 citations
959 days after retraction
Glucosamine Enhances TRAIL-Induced Apoptosis in the Prostate Cancer Cell Line DU145
Chao Sun, Viktor Chesnokov, Garrett P. Larson et al. (4 authors)
Medicines
Open Access
Published: Oct 2019
6 citations
6 citations
946 days after retraction
The combination of <i>TPL2</i> knockdown and TNFα causes synthetic lethality via caspase-8 activation in human carcinoma cell lines
Oksana B. Serebrennikova, Maria D. Paraskevopoulou, Elia Aguado-Fraile et al. (10 authors)
Proceedings of the National Academy of Sciences
Open Access
Published: Jun 2019
8 citations
8 citations
834 days after retraction
ISG12a and its interaction partner NR4A1 are involved in TRAIL‐induced apoptosis in hepatoma cells
Nianli Liu, Zhiyuan Wu, Aoxing Chen et al. (7 authors)
Journal of Cellular and Molecular Medicine
Open Access
Published: Mar 2019
14 citations
14 citations
718 days after retraction
MicroRNA regulation of TRAIL mediated signaling in different cancers: Control of micro steering wheels during the journey from bench-top to the bedside
Sundas Fayyaz, Zeeshan Javed, Rükset Attar et al. (6 authors)
Seminars in Cancer Biology
Published: Feb 2019
18 citations
18 citations
690 days after retraction
Research progress on the relationship between lung cancer drug-resistance and microRNAs
Xuan Ma, Ai‐Ling Liang, Yongjun Liu
Journal of Cancer
Open Access
Published: Jan 2019
21 citations
21 citations
659 days after retraction
<i>Retracted</i>: Effects of ebv‐miR‐BART7 on tumorigenicity, metastasis, and TRAIL sensitivity of non‐small cell lung cancer
Lei Wang, Li‐fa Liu, Li Zhou et al. (5 authors)
Journal of Cellular Biochemistry
Open Access
Published: Dec 2018
8 citations
8 citations
646 days after retraction
miRNA-mediated TUSC3 deficiency enhances UPR and ERAD to promote metastatic potential of NSCLC
Young-Jun Jeon, Tae‐Wan Kim, Dongju Park et al. (25 authors)
Nature Communications
Open Access
Published: Nov 2018
44 citations
44 citations
623 days after retraction
Downregulation of microRNA‑30a in bronchoalveolar lavage fluid from idiopathic pulmonary fibrosis patients
Bao Liu, Tingshu Jiang, Xingang Hu et al. (8 authors)
Molecular Medicine Reports
Open Access
Published: Oct 2018
37 citations
37 citations
584 days after retraction
Targeting IKKβ in Cancer: Challenges and Opportunities for the Therapeutic Utilisation of IKKβ Inhibitors
Jack A. Prescott, Simon J. Cook
Cells
Open Access
Published: Aug 2018
115 citations
115 citations
528 days after retraction
The upregulation of TMPRSS4, partly ascribed to the downregulation of miR‑125a‑5p, promotes the growth of human lung adenocarcinoma via the NF‑κB signaling pathway
Xiaoxi Fan, Yicheng Liang, Yang Liu et al. (6 authors)
International Journal of Oncology
Open Access
Published: May 2018
15 citations
15 citations
420 days after retraction
lncRNA NEAT1 competes against let-7a to contribute to non-small cell lung cancer proliferation and metastasis
Qi Li, Fang Liu, Feng Zhang et al. (7 authors)
Biomedicine & Pharmacotherapy
Published: May 2018
75 citations
75 citations
420 days after retraction
The mechanism study of lentiviral vector carrying methioninase enhances the sensitivity of drug-resistant gastric cancer cells to Cisplatin
Xin Lin, Weifeng Yang, Hou‐Ting Zhang et al. (5 authors)
British Journal of Cancer
Open Access
Published: Mar 2018
23 citations
23 citations
378 days after retraction
NanoTRAIL‐Oncology: A Strategic Approach in Cancer Research and Therapy
Yesi Shi, Xin Pang, Junqing Wang et al. (4 authors)
Advanced Healthcare Materials
Published: Mar 2018
16 citations
16 citations
364 days after retraction
Oncogene-induced regulation of microRNA expression: Implications for cancer initiation, progression and therapy
Athanasios R. Paliouras, Tiziana Monteverde, Michela Garofalo
Cancer Letters
Published: Feb 2018
36 citations
36 citations
345 days after retraction
Paper citing EGFR and MET receptor tyrosine kinase–altered micr...
Unknown Authors
Unknown Journal
Published: Feb 2018
343 days after retraction
KRAS induces lung tumorigenesis through microRNAs modulation
Lei Shi, Justin Middleton, Young-Jun Jeon et al. (13 authors)
Cell Death and Disease
Open Access
Published: Feb 2018
52 citations
52 citations
337 days after retraction
A DR4 capturer with AKT siRNA for the synergetic enhancement of death receptor-mediated apoptosis
Wei Pan, Shaohua Gong, Yanhua Li et al. (6 authors)
Chemical Communications
Published: Jan 2018
4 citations
4 citations
294 days after retraction
Stage-dependent therapeutic efficacy in PI3K/mTOR-driven squamous cell carcinoma of the skin
Charbel Darido, Smitha R. Georgy, Carleen Cullinane et al. (11 authors)
Cell Death and Differentiation
Open Access
Published: Dec 2017
38 citations
38 citations
275 days after retraction
Bcl-2 Antiapoptotic Family Proteins and Chemoresistance in Cancer
Santanu Maji, Sanjay Panda, Sabindra K. Samal et al. (10 authors)
Advances in cancer research
Published: Dec 2017
190 citations
190 citations
268 days after retraction
PDGFR-modulated miR-23b cluster and miR-125a-5p suppress lung tumorigenesis by targeting multiple components of KRAS and NF-kB pathways
Srivatsava Naidu, Lei Shi, Peter Magee et al. (13 authors)
Scientific Reports
Open Access
Published: Nov 2017
53 citations
53 citations
239 days after retraction
Related Records
This article has multiple records in the database due to different notices:
Record #32483
Aug 31, 2021Quick Stats
Total Citations:
71
Years Since Retraction:
8.7 years
Open Access:
Yes
Last Checked:
Never